No Picture
News

IMV’s DPX Delivery Technology to be Showcased in Two e-Posters at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics

DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.–(BUSINESS WIRE)—- $IMV #DeliveryPlatform–IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies against difficult-to-treat cancers, today announced that two abstracts featuring two DPX-based immunotherapies have been accepted for virtual poster presentation at the upcoming AACR-NCI-EORTC Virtual International Conference… Click here to view original post… […]

No Picture
News

Nimbus Therapeutics Publishes Structural Analysis Highlighting Mechanisms for Selective Inhibition of CTPS1

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today published research in the Proceedings of the National Academy of Sciences describing the structural basis for isoform-specific inhibition of human CTPS1 (CTP synthase 1). Selective inhibition of CTPS1 is a promising approach for… Click here to view original post… […]

No Picture
News

Spero strikes $125M royalty deal for cUTI drug; French firm launches $100M early biotech fund

French investment firm Advent France Biotechnology (AFB) announced today the first closing of its second fund for a total of $102 million. Investors and participants in AFB’s fund included the European Investment Fund (EIF) and the Fonds national d’amorçage 2 (the French Seed Fund 2), which… Click here to view original post… […]

No Picture
News

Continuing to chart post-Covid path, Moderna will build new science center near Massachusetts headquarters

As Moderna continues to balloon into one of the largest market caps in the world, the biotech at the forefront of the Covid-19 vaccine field is seeking to continue capitalizing on its newfound fortune. Moderna announced Thursday it will be constructing a new science center near its Cambridge, MA headquarters,… Click here to view original post… […]

No Picture
News

Amy Salzhauer And Greg Miller Join The Board Of ABM Respiratory Care

SINGAPORE: SINGAPORE, Sept. 30, 2021 /PRNewswire/ — ABM Respiratory Care, a medical technology company focused on developing and globally commercializing novel integrated airway clearance and ventilation solutions, announced today the appointment of Amy Salzhauer and Greg Miller to the company’s Board of Directors. Ms. Salzhauer currently serves as a Founder… Click here to view original post… […]

No Picture
News

Alexandria Real Estate Equities, Inc. Deepens and Expands Strategic Relationship With Moderna for New 462,000 RSF HQ and R&D Facility at 325 Binney Street, Designed to Be the Most Sustainable Laboratory Building in Cambridge

PASADENA, Calif. and CAMBRIDGE, Mass.: PASADENA, Calif. and CAMBRIDGE, Mass., Sept. 30, 2021 /PRNewswire/ — Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life science, agtech and technology campuses in AAA innovation cluster… Click here to view original post… […]

No Picture
News

Inflammasome Therapeutics’ Kamuvudines Continue to Show Promise for Future Treatment – and Potentially a Cure – for Blindness in Seniors

NEWTON, Mass.–(BUSINESS WIRE)– #AMD–New research points to Inflammasome’s Kamuvudines Continue to Show Promise for Future Treatment – and Potentially Cure – for Blindness in Aged Click here to view original post… […]